Pharmacology: Basic Concepts Flashcards
Pharmacology
Study of drugs and their interactions with living systems
Therapeutics
The use of drugs to diagnose, prevent pregnancy, or treat disease states
Pharmacokinetics
The study of how living systems process drugs
Pharmacodynamics
The study of how drugs affect living systems
Pharmacogenomics
The study of how genetics affect our drug response
ADME: what does it stand for and does it fall under pharmacokinetics or pharmacodynamics?
Absorption, Distribution, Metabolism, Excretion
Pharmacokinetics
Drug-receptor interactions, patient’s functional state, placebo effects… these fall under pharmacokinetics or pharmacodynamics?
Pharmacodynamics
Schedule I Drugs
High abuse potential with no accepted medical uses
Schedule II drugs
High abuse potential WITH accepted medical uses (opiates, methylphenidate)
Schedule III drugs
Abuse potential, but less than I or II
(Codeine, steroids, pseudoephedrine - IN OREGON ONLY). Can differ from one state to the next.
Schedule IV drugs
Include benzos
Schedule V drugs
Include cough medicine
Pregnancy Categories A, B, C, D, X
A: no risk to fetus in 1st trimester
B: no well controlled human studies, but no risk in animal studies
C: animal studies have adverse effects, but in humans benefits outweigh risks
D: Fetal risk. Only really ok if no safer alternative
X: Fetal abnormalities. Don’t use
Clinical trial Phase I purpose
First in human studies
Healthy volunteers
Know what they’re taking.
Goal is to assess safety and tolerability
Clinical Trial Phase II
First in patient studies
Patients receive drug
Randomized, controlled, maybe blind
Goal: correct dose and efficacy
Clinical Trials phase 3
Hundreds of thousands of patients
Randomized, controlled, maybe blind
Best phase to gather info from.
Clinical Trials phase IV
Post-marketing surveillance.
DDIs, AEs.
Simple Occupancy Theory
The number of places a drug binds to a receptor is proportional to the intensity of the effects.
Modified Occupancy Theory
Strength of the attraction between drug and receptor affects the potency of the drug. Drugs with lower affinity require higher concentrations to bind.
Intrinsic activity
The ability of a drug to activate a receptor to produce an effect
Noncompetitive antagonists
Bind irreversibly to an allosteric site
Fewer available receptors reduces the maximum possible effect.
Adding more agonist doesn’t help because the receptor sites have changed.
Competitive antagonists
Compete for receptors with equal affinity as the agonists.
Bind reversibly, so whichever has the most creates the strongest effect.
Partial agonists
Can’t produce a 100% effect, no matter how much you give.